Co-Producer
|
|
| May
1, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
|
Join
us September 30 – October 1 for
LSPA’s largest partnering event of
the year. Connect with the life
sciences ecosystem throughout the
Commonwealth and beyond, get the
latest information through timely
panel discussions and learn about
the newest innovations shaping the
industry.
|
|
Learn More
→ |
|
|
- AstraZeneca: TRUQAP (Capivasertib)
Recommended by FDA Advisory Committee for
PTEN-Deficient Metastatic Hormone-Sensitive
Prostate Cancer More
- Larimar Therapeutics: Publishes
Cross-Species Findings Supporting Skin as a
Surrogate for the Measurement of Frataxin in
Tissues Clinically Relevant to Friedreich's
Ataxia More
- Made Scientific: Strengthens Board to
Support Scale-Up and Commercial Readiness in
Cell Therapy Manufacturing More
- Orchestra BioMed: FDA Grants Additional
Breakthrough Device Designation for AVIM
Therapy More
|
|
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- BMS Calls Time on Zymeworks Collab,
Ending Work on Phase 1 Cancer Bispecific More
- BMS 'Well Prepared' for Camzyos
Competition as Revenue From New Products
Overtakes Legacy Portfolio More
- LSN: Hot Investor Mandate (Updated 4/28) More
- TELA Bio: Strategic Board Refreshment With
Four Highly Experienced Commerical Leaders to
Accelerate Growth and Drive Path to
Profitability; The Company Also Reports
Preliminary First Quarter 2026 Revenues More
- Temple and AtlantiCare: Formalize Agreement
to Establish New Medical School Campus More
More*
|
|
 |
Pace®
Life Sciences
The CDMO That Takes You Further.
Your partner for Product
Development, Manufacturing,
Analytical Testing, Regulatory
Consulting & Operational
Support. |
|
Learn More
→ |
|
|
- AstraZeneca's Camizestrant Ambitions
Stumble as FDA Panel Rejects Novel Oral SERD
Proposal More
More*
More*
- BioPharmGuy News: Triple Dystopia,
F.I.E.R.C.E. Values, Beauty of Optics, Oatmeal
Acquisition More
- Bristol Myers' Krazati Fails Confirmatory
Trial in Colorectal Cancer, Putting Approval
at Risk More*
- More on Teleflex Hiring Jason Weidman as CEO
More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- Updated:
Analysts Focus on Three Pipeline Programs in
Pivotal Year for Bristol Myers More*
|
|
 |
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- AI in Biotech: The New Frontier for
Leadership & Strategy More
- Biopharmas Pull Back on Layoffs in Q1 More
- CollectiveMinds: Places Keith
Meadors as Chief Commercial Officer at Genova
Diagnostics More
- Empowering Students through STEM: A
Conversation With Massachusetts Science &
Engineering Fair Executive Director Helen
Rosenfeld More
- From Seed to Series C: What
Investors Look for Beyond the Science More
- M&A in Life Sciences: The Turning Tide –
Why Now is a Strategic Inflection for
Biopharma and Biotech More
- More Than Executive Search: Building
Leadership for Every Stage of Growth More
- Novo’s Double Departures: As GLP-1 Luminary
Retires, an Obesity Leader Goes to Boehringer
Ingelheim More*
- SJU: Path to Commercialization in Healthcare
- Otsuka's Amy Whitcomb (Content
Management) is Interviewed by Maxwell Rosada
& Jon Evoy Podcast
- Telling Your Science Story to Investors More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Philadelphia Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Philadelphia,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
